Related Experiment Videos
An update on thrombolytic therapy for acute stroke.
Peter D Schellinger1, Markku Kaste, Werner Hacke
1Department of Neurology, University Hospital, Heidelberg, Germany. peter_schellinger@med.uni-heidelberg.de
Current Opinion in Neurology
|April 20, 2004
Summary
Thrombolysis is an effective treatment for acute ischemic stroke, improving outcomes when guided by advanced imaging beyond traditional time windows. This approach personalizes stroke care, aiming to reduce disability and the socioeconomic burden of stroke.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Medical Imaging
Background:
- Stroke is a leading cause of death and disability globally.
- Thrombolysis is the primary treatment for acute ischemic stroke within 3 hours.
- Current treatment often relies on rigid time windows, potentially excluding eligible patients.
Purpose of the Study:
- To provide an overview of thrombolytic therapy in acute stroke.
- To present a diagnostic approach for individualized stroke management.
- To develop a treatment algorithm based on pathophysiological reasoning and advanced imaging.
Main Methods:
- Review of current thrombolytic therapy status in stroke.
- Development of a treatment algorithm using multiparametric stroke magnetic resonance imaging (MRI).
- Integration of pathophysiological information for patient selection.
Main Results:
- Thrombolysis is effective intravenously (3h) and intra-arterially (3-6h).
- Evidence supports extended thrombolysis beyond 3 hours with advanced MRI selection criteria.
- Thrombolytic therapy remains underutilized despite proven efficacy.
Conclusions:
- Personalized stroke management using advanced MRI can optimize thrombolysis.
- Expanding treatment eligibility criteria may increase thrombolysis use.
- Increased adoption of effective thrombolysis can reduce the socioeconomic impact of stroke.